Carcinoma Renal Cell
📧 Sign up to get email alerts when something new happens for Carcinoma Renal Cell.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2021-11-25EMA Withdrawn: Equidacent (bevacizumab) — Centus Biotherapeutics Europe Limited
Equidacent (bevacizumab) has been withdrawn from the market in the European Medicines Agency record.